Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Second-Line Treatment Choice for Epilepsy

NCT00208520 is registered in ClinicalTrials.gov with Dutch Epilepsy Clinics Foundation as lead sponsor.

NCT NCT00208520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00208520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Second-Line Treatment Choice for Epilepsy
Lead sponsor
Dutch Epilepsy Clinics Foundation
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2003
Completion date
June 30, 2007
Enrollment
60
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adults with tonic clonic seizures and/or partial seizures